Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 Oct;66(4):670–675. doi: 10.1172/JCI109903

Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex.

C Murray, D L Mann, L N Gerber, W Barth, S Perlmann, J L Decker, T P Nigra
PMCID: PMC371640  PMID: 6932404

Abstract

The frequency of HLA-A, B, and Cw antigens as well as the antigens expressed preferentially on B cells and monocytes (DRw and Ia-like) was examined in a normal population and two related disease populations, psoriasis and psoriatic arthritis. HLA antigens distinguishing the two disease populations were found. Psoriatic patients demonstrated an increase in frequency of HLA-A1, B17, and B13. Patients with psoriatic arthritis demonstrated an increased frequency of HLA-A26, B38, and DRw4. Antigens showing a common increase in frequency in the two disease populations were HLA-Cw6, DRw7, and Ia744. These results demonstrate genetic differences as well as similarities in the two populations of patients with the common clinical feature of psoriasis. In addition to the above analysis, we examined the association of individual alloantigens elevated in frequency in the diseased population. These same alloantigens were examined for association in the normal population. This analysis revealed HLA antigen associations in the two disease groups that differed from the association of several antigens in the normal population. The results suggest that at least two genetic factors, one mapping in the HLA-A, C-B region and one mapping in the HLA-B-DRw region are associated with the disease states. Thus, multiple factors controlled by genes in the major histocompatibility complex appear to contribute to the disease entities under investigation.

Full text

PDF
670

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Espinoza L. R., Vasey F. B., Oh J. H., Wilkinson R., Osterland C. K. Association between HLA-BW38 and peripheral psoriatic arthritis. Arthritis Rheum. 1978 Jan-Feb;21(1):72–75. doi: 10.1002/art.1780210112. [DOI] [PubMed] [Google Scholar]
  2. Gazit E., Brenner S., Efter T., Orgad S., Mizrachi Y., Krakowski A. HLA antigens in patients with psoriasis. Tissue Antigens. 1978 Sep;12(3):195–199. doi: 10.1111/j.1399-0039.1978.tb01322.x. [DOI] [PubMed] [Google Scholar]
  3. Gunn I., Leheny W., Lakshmipathi T., Lamont M. A., Faed M. HLA antigens in a Scottish psoriatic population. Tissue Antigens. 1979 Aug;14(2):157–164. doi: 10.1111/j.1399-0039.1979.tb00833.x. [DOI] [PubMed] [Google Scholar]
  4. Kimberling W., Dobson R. L. The inheritance of psoriasis. J Invest Dermatol. 1973 Jun;60(6):538–540. doi: 10.1111/1523-1747.ep12703617. [DOI] [PubMed] [Google Scholar]
  5. Krain L. S., Newcomer V. D., Terasaki P. I. HL-A antigen in psoriasis. N Engl J Med. 1973 Jun 7;288(23):1245–1245. doi: 10.1056/nejm197306072882321. [DOI] [PubMed] [Google Scholar]
  6. Mann D. L., Abelson L., Henkart P., Harris S. D., Amos D. B. Specific human B lymphocyte alloantigens linked to HL-A. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5103–5106. doi: 10.1073/pnas.72.12.5103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mann D. L., Kaufman J., Orr H., Robb R., Strominger J. Serologic and structural studies of DR-related antigens. Transplant Proc. 1979 Mar;11(1):668–673. [PubMed] [Google Scholar]
  8. Marcusson J., Möller E., Thyresson N. HL-A antigens (17, 27, UPS) in psoriasis with special reference to patients with arthritic lesions. Acta Derm Venereol. 1975;55(4):297–300. [PubMed] [Google Scholar]
  9. McMichael A. J., Morhenn V., Payne R., Sasazuki T., Farber E. M. HLA C and D antigens associated with psoriasis. Br J Dermatol. 1978 Mar;98(3):287–292. doi: 10.1111/j.1365-2133.1978.tb06155.x. [DOI] [PubMed] [Google Scholar]
  10. Moll J. M., Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55–78. doi: 10.1016/0049-0172(73)90035-8. [DOI] [PubMed] [Google Scholar]
  11. Park M. S., Terasaki P. I., Ahmed A. R., Tiwari J. L. HLA-DRW4 in 91% of Jewish pemphigus vulgaris patients. Lancet. 1979 Sep 1;2(8140):441–442. doi: 10.1016/s0140-6736(79)91493-4. [DOI] [PubMed] [Google Scholar]
  12. Roux H., Mercier P., Maestracci D., Serratrice G., Sany J., Seignalet J., Serre H. Psoriatic arthritis and HLA antigens. J Rheumatol Suppl. 1977;3:64–65. [PubMed] [Google Scholar]
  13. Russell T. J., Schultes L. M., Kuban D. J. Histocompatibility (HL-A) antigens associated with psoriasis. N Engl J Med. 1972 Oct 12;287(15):738–740. doi: 10.1056/NEJM197210122871503. [DOI] [PubMed] [Google Scholar]
  14. Seignalet J., Clot J., Guilhou J. J., Duntze F., Meynadier J., Robinet-Levy M. HL-A antigens and some immunological parameters in psoriasis. Tissue Antigens. 1974;4(1):59–68. doi: 10.1111/j.1399-0039.1974.tb00226.x. [DOI] [PubMed] [Google Scholar]
  15. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978 Apr 20;298(16):869–871. doi: 10.1056/NEJM197804202981602. [DOI] [PubMed] [Google Scholar]
  16. Stingl G., Katz S. I., Abelson L. D., Mann D. L. Immunofluorescent detection of human B cell alloantigens on S-Ig-positive lymphocytes and epidermal Langerhans cells. J Immunol. 1978 Feb;120(2):661–664. [PubMed] [Google Scholar]
  17. Svejgaard A., Nielsen L. S., Svejgaard E., Nielsen F. K., Hjortshoj A., Zachariae H. HL-A in psoriasis vulgaris and in pustular psoriasis--population and family studies. Br J Dermatol. 1974 Aug;91(2):145–153. doi: 10.1111/j.1365-2133.1974.tb15859.x. [DOI] [PubMed] [Google Scholar]
  18. Voorhees J. J., Duell E. A., Stawiski M., Harrell E. R. Cyclic nucleotide metabolism in normal and proliferating epidermis. Adv Cyclic Nucleotide Res. 1974;4(0):117–162. [PubMed] [Google Scholar]
  19. Watson W., Cann H. M., Farber E. M., Nall M. L. The genetics of psoriasis. Arch Dermatol. 1972 Feb;105(2):197–207. [PubMed] [Google Scholar]
  20. Weinstein G. D., Frost P. Methotrexate for psoriasis. A new therapeutic schedule. Arch Dermatol. 1971 Jan;103(1):33–38. [PubMed] [Google Scholar]
  21. White S. H., Newcomer V. D., Mickey M. R., Terasaki P. I. Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med. 1972 Oct 12;287(15):740–743. doi: 10.1056/NEJM197210122871504. [DOI] [PubMed] [Google Scholar]
  22. Woodrow J. C., Dave V. K., Usher N., Anderson J. The HL-A system and psoriasis. Br J Dermatol. 1975 Apr;92(4):427–436. doi: 10.1111/j.1365-2133.1975.tb03104.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES